z-logo
Premium
Prostaglandin E 2 ‐induced modification of tetrodotoxin‐resistant Na + currents involves activation of both EP 2 and EP 4 receptors in neonatal rat nodose ganglion neurones
Author(s) -
Matsumoto Shigeji,
Ikeda Mizuho,
Yoshida Shinki,
Tanimoto Takeshi,
Takeda Mamoru,
Nasu Masanori
Publication year - 2005
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0706212
Subject(s) - nodose ganglion , agonist , staurosporine , receptor , endocrinology , medicine , prostaglandin e2 receptor , extracellular , chemistry , biology , microbiology and biotechnology , signal transduction , protein kinase c , vagus nerve , biochemistry , stimulation
1 The aim of the present study was to investigate which EP receptor subtypes (EP 1 –EP 4 ) act predominantly on the modification of the tetrodotoxin‐resistant Na + current ( I NaR ) in acutely isolated neonatal rat nodose ganglion (NG) neurones. 2 Of the four EP receptor agonists ranging from 0.01 to 10  μ M , the EP 2 receptor agonist (ONO‐AE1‐259, 0.1–10  μ M ) and the EP 4 receptor agonist (ONO‐AE1‐329, 1  μ M ) significantly increased peak I NaR . The responses were associated with a hyperpolarizing shift in the activation curve. 3 Neither the EP 1 receptor agonist ONO‐DI‐004 nor the EP 3 receptor agonist ONO‐AE‐248 significantly modified the properties of I NaR . 4 In PGE 2 applications ranging from 0.01 to 10  μ M , 1  μ M PGE 2 produced a maximal increase in the peak I NaR amplitude. The PGE 2 (1  μ M )‐induced increase in the GV 1/2 baseline (% change in G at baseline V 1/2 ) was significantly attenuated by either intracellular application of the PKA inhibitor PKI or extracellular application of the protein kinase C inhibitor staurosporine (1  μ M ). However, the slope factor k was not significantly altered by PGE 2 applications at 0.01–10  μ M . In addition, the hyperpolarizing shift of V 1/2 by PGE 2 was not significantly altered by either PKI or staurosporine. 5 In other series of experiments, reverse transcription–polymerase chain reaction (RT–PCR) of mRNA from nodose ganglia indicated that all four EP receptors were present. 6 The NG contained many neuronal cell bodies (diameter <30  μ m) with intense or moderate EP 2 , EP 3 , and EP 4 receptor‐immunoreactivities. 7 These results suggest that the PGE 2 ‐induced modification of I NaR is mainly mediated by activation of both EP 2 and EP 4 receptors.British Journal of Pharmacology (2005) 145 , 503–513. doi: 10.1038/sj.bjp.0706212

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom